1. Tumor-associated fibrosis: a unique mechanism promoting ovarian cancer metastasis and peritoneal dissemination
    Hiroki Fujimoto et al, 2024, Cancer and Metastasis Reviews CrossRef
  2. Synergistic enhancement of efficacy of platinum drugs with verteporfin in ovarian cancer cells
    Venkata Ramesh Dasari et al, 2020, BMC Cancer CrossRef
  3. Icariin promotes proliferation and osteogenic differentiation of rat adipose-derived stem cells by activating the RhoA-TAZ signaling pathway
    Yaping Ye et al, 2017, Biomedicine & Pharmacotherapy CrossRef
  4. Fixing the GAP: The role of RhoGAPs in cancer
    Gabriel Kreider-Letterman et al, 2022, European Journal of Cell Biology CrossRef
  5. The RNA binding protein QKI5 suppresses ovarian cancer via downregulating transcriptional coactivator TAZ
    Tao Liu et al, 2021, Molecular Therapy - Nucleic Acids CrossRef
  6. The YAP/TAZ Signaling Pathway in the Tumor Microenvironment and Carcinogenesis: Current Knowledge and Therapeutic Promises
    Ángel Ortega et al, 2021, International Journal of Molecular Sciences CrossRef
  7. TAZ is involved in breast cancer cell migration via regulating actin dynamics
    Hong Seok Choi et al, 2024, Frontiers in Oncology CrossRef
  8. ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer
    Chen-Ying Liu et al, 2017, Journal of Biological Chemistry CrossRef
  9. Integrins in Ovarian Cancer: Survival Pathways, Malignant Ascites and Targeted Photochemistry
    Mustafa Kemal Ruhi et al, 2023, Recent Advances, New Perspectives and Applications in the Treatment of Ovarian Cancer CrossRef
  10. N-oleoylethanolamide treatment of lymphoblasts deficient in Tafazzin improves cell growth and mitochondrial morphology and dynamics
    John Z. Chan et al, 2022, Scientific Reports CrossRef
  11. TAZ Regulates the Cisplatin Resistance of Epithelial Ovarian Cancer Cells via the ANGPTL4/SOX2 Axis
    Caihong Li et al, 2022, Analytical Cellular Pathology CrossRef
  12. High expression of LASS2 is associated with unfavorable prognosis in patients with ovarian cancer
    Ning Sheng et al, 2019, Journal of Cellular Physiology CrossRef
  13. The Hippo pathway in normal development and cancer
    Marcello Maugeri-Saccà et al, 2018, Pharmacology & Therapeutics CrossRef
  14. Molecular signatures of X chromosome inactivation and associations with clinical outcomes in epithelial ovarian cancer
    Stacey J Winham et al, 2019, Human Molecular Genetics CrossRef
  15. Rottlerin inhibits cell growth, induces apoptosis and cell cycle arrest, and inhibits cell invasion in human hepatocellular carcinoma
    Jichan Shi et al, 2017, Molecular Medicine Reports CrossRef
  16. Role of DCLK1/Hippo pathway in type II alveolar epithelial cells differentiation in acute respiratory distress syndrome
    Xiao-Yue Chen et al, 2023, Molecular Medicine CrossRef
  17. Transcriptional co-activators: emerging roles in signaling pathways and potential therapeutic targets for diseases
    Priyanka Dey Talukdar et al, 2023, Signal Transduction and Targeted Therapy CrossRef
  18. Hippo pathway contributes to cisplatin resistant-induced EMT in nasopharyngeal carcinoma cells
    Shuo Li et al, 2017, Cell Cycle CrossRef
  19. Emerging role of Hippo signalling pathway in bladder cancer
    Jianling Xia et al, 2018, Journal of Cellular and Molecular Medicine CrossRef
  20. DUB1 suppresses Hippo signaling by modulating TAZ protein expression in gastric cancer
    Dehai Wang et al, 2022, Journal of Experimental & Clinical Cancer Research CrossRef
  21. An integrative approach to assess X‐chromosome inactivation using allele‐specific expression with applications to epithelial ovarian cancer
    Nicholas B. Larson et al, 2017, Genetic Epidemiology CrossRef
  22. Amplification of Hippo Signaling Pathway Genes Is Governed and Implicated in the Serous Subtype-Specific Ovarian Carcino-Genesis
    Karthik Balakrishnan et al, 2024, Cancers CrossRef
  23. YAP/TAZ: Drivers of Tumor Growth, Metastasis, and Resistance to Therapy
    Barry J. Thompson, 2020, BioEssays CrossRef
  24. Immunotherapy checkpoints in ovarian cancer vasculogenic mimicry: Tumor immune microenvironments, and drugs
    Haitao Hu et al, 2022, International Immunopharmacology CrossRef
  25. Mechanism of MicroRNA-375 Promoter Methylation in Promoting Ovarian Cancer Cell Malignancy
    Junjun Shu et al, 2021, Technology in Cancer Research & Treatment CrossRef